Table 2.
30-day adverse events.
| All n = 166 | |
|---|---|
| Reinfarction | 8 (5%) |
| Definite stent thrombosis | 3 (2%) |
| Ischemic stroke | 1 (1%) |
| Haemorrhagic stroke | 3 (2%) |
| Peripheral ischemia of the leg requiring Surgery or intervention | 15 (9%) |
| Haemolysis | 31 (19%) |
| Bleeding (based on GUSTO definitions (25)) | |
| Life-threatening/severe | 9 (5%) |
| Moderate | 27 (16%) |
| Mild | 33 (20%) |
| Sepsis | 50 (30%) |
| Renal replacement therapy | 84 (51%) |